Abilify (aripiprazole), 10 mg tablets, packaged in a) 30 count bottles (NDC 59148-008-13) and b) 7 count blister packs (NDC 59148-008-95), RX only, Otsuka America Pharmaceutical, Inc.
Published May 1, 2024 · Recall initiated: April 9, 2024
Summary
FDA records drug Class III recall D-0467-2024, published May 1, 2024 and initiated April 9, 2024. Recalling firm: Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.; Status: Ongoing; Reported quantity: N/A; Lot: Lot #: a) ALS00422A, Exp 04/30/2025; ALS00523A, Exp 11/30/2025; b) 1K77YUD1H1A, Exp 11/30/2024. Class III means the product is not likely to cause adverse health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Cross Contamination with Other Products
What to do
Voluntary: Firm initiated · Letter
Get an email if ABILIFY has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ABILIFY
- Manufacturer
- Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
- Distributor
- USA nationwide.
- Lot
- Lot #: a) ALS00422A, Exp 04/30/2025; ALS00523A, Exp 11/30/2025; b) 1K77YUD1H1A, Exp 11/30/2024
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- Japan
Related recalls
- FDAAbilify (aripiprazole), 15 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical,May 1, 2024
- FDAAbilify (aripiprazole), 5 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical,May 1, 2024
- FDAAbilify (aripiprazole), 30 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical,May 1, 2024
- FDAFUL-GLO, Fluorescein Sodium Ophthalmic Strips USP 1 mg, 100 sterile strips per carton, Manufactured for:May 1, 2024
- FDAFUL-GLO, Fluorescein Sodium Sterile Ophthalmic Strips USP (0.6 mg Fluorescein), 300 sterile strips per carton,May 1, 2024
- FDAABILIFY (aripiprazole) Tablets, 30 mg, Rx only, Blister Pack of 100 tablets, Otsuka America PharmaceuticalMarch 13, 2013
Questions about this recall
Was Abilify (aripiprazole), 10 mg tablets, packaged in a) 30 count bottles (NDC 59148-008-13) and b) 7 count blister packs (NDC 59148-008-95), RX only, Otsuka America Pharmaceutical, Inc. recalled?
Yes. FDA published recall D-0467-2024 on May 1, 2024. Reported hazard: Cross Contamination with Other Products
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ABILIFY.